147 related articles for article (PubMed ID: 16317594)
1. [Myopathy with trabecular fibers associated with familiar autoimmune polyglandular syndrome type 1].
Gazulla Abío J; Benavente Aguilar I; Ricoy Campo JR; Madero Barrajón P
Neurologia; 2005 Dec; 20(10):702-8. PubMed ID: 16317594
[TBL] [Abstract][Full Text] [Related]
2. Novel and recurrent mutations in the AIRE gene of autoimmune polyendocrinopathy syndrome type 1 (APS1) patients.
Faiyaz-Ul-Haque M; Bin-Abbas B; Al-Abdullatif A; Abdullah Abalkhail H; Toulimat M; Al-Gazlan S; Almutawa AM; Al-Sagheir A; Peltekova I; Al-Dayel F; Zaidi SH
Clin Genet; 2009 Nov; 76(5):431-40. PubMed ID: 19758376
[TBL] [Abstract][Full Text] [Related]
3. Myopathy in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Watanabe M; Ochi H; Arahata H; Matsuo T; Nagafuchi S; Ohyagi Y; Kira J
Muscle Nerve; 2012 Jun; 45(6):904-8. PubMed ID: 22581549
[TBL] [Abstract][Full Text] [Related]
4. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
Jungbluth H; Zhou H; Hartley L; Halliger-Keller B; Messina S; Longman C; Brockington M; Robb SA; Straub V; Voit T; Swash M; Ferreiro A; Bydder G; Sewry CA; Müller C; Muntoni F
Neurology; 2005 Dec; 65(12):1930-5. PubMed ID: 16380615
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune polyglandular syndrome type 1 and the autoimmune regulator.
Ruan QG; She JX
Clin Lab Med; 2004 Mar; 24(1):305-17. PubMed ID: 15157567
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity.
Peterson P; Peltonen L
J Autoimmun; 2005; 25 Suppl():49-55. PubMed ID: 16290093
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes.
Ballarini A; Lee-Kirsch MA
Ann N Y Acad Sci; 2007 Sep; 1110():159-65. PubMed ID: 17911431
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives.
Cervato S; Mariniello B; Lazzarotto F; Morlin L; Zanchetta R; Radetti G; De Luca F; Valenzise M; Giordano R; Rizzo D; Giordano C; Betterle C
Clin Endocrinol (Oxf); 2009 Mar; 70(3):421-8. PubMed ID: 18616706
[TBL] [Abstract][Full Text] [Related]
9. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
Lankisch TO; Jaeckel E; Strassburg CP
Semin Liver Dis; 2009 Aug; 29(3):307-14. PubMed ID: 19676003
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune polyglandular syndromes].
Krysiak R; Okopien B; Bołdys A
Przegl Lek; 2008; 65(9):393-400. PubMed ID: 19140388
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.
Meloni A; Willcox N; Meager A; Atzeni M; Wolff AS; Husebye ES; Furcas M; Rosatelli MC; Cao A; Congia M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1114-24. PubMed ID: 22344197
[TBL] [Abstract][Full Text] [Related]
12. Population genetics and functions of the autoimmune regulator (AIRE).
Kumar PG; Laloraya M; She JX
Endocrinol Metab Clin North Am; 2002 Jun; 31(2):321-38, vi. PubMed ID: 12092453
[TBL] [Abstract][Full Text] [Related]
13. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
[TBL] [Abstract][Full Text] [Related]
14. [A case of autoimmune polyglandular deficiency associated with progressive myopathy].
Segawa F; Yamada H; Tomi H; Sunohara N; Nonaka I
Rinsho Shinkeigaku; 1992 May; 32(5):501-5. PubMed ID: 1458727
[TBL] [Abstract][Full Text] [Related]
15. A mutation in myotilin causes spheroid body myopathy.
Foroud T; Pankratz N; Batchman AP; Pauciulo MW; Vidal R; Miravalle L; Goebel HH; Cushman LJ; Azzarelli B; Horak H; Farlow M; Nichols WC
Neurology; 2005 Dec; 65(12):1936-40. PubMed ID: 16380616
[TBL] [Abstract][Full Text] [Related]
16. Clearing the AIRE: on the pathophysiological basis of the autoimmune polyendocrinopathy syndrome type-1.
Shikama N; Nusspaumer G; Holländer GA
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):273-88, vii. PubMed ID: 19328411
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune polyglandular syndromes.
Obermayer-Straub P; Manns MP
Baillieres Clin Gastroenterol; 1998 Jun; 12(2):293-315. PubMed ID: 9890074
[TBL] [Abstract][Full Text] [Related]
18. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms].
Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O
Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin-deficient anemia associated with autoimmune polyglandular syndrome type I.
Toonkel R; Levine M; Gardner L
Am J Hematol; 2004 Feb; 75(2):84-8. PubMed ID: 14755373
[TBL] [Abstract][Full Text] [Related]
20. [AIRE gene mutation in polyglandular syndrome type 1].
Martínez López MM; González Casado I; Alvarez Doforno R; Delgado Cerviño E; Gracia Bouthelier R
An Pediatr (Barc); 2006 Jun; 64(6):583-7. PubMed ID: 16792967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
